Immunizations with hepatitis B viral antigens and a TLR7/8 agonist adjuvant induce antigen-specific immune responses in HBV-transgenic mice

Background: The capacity of toll-like receptor (TLR) 7/8 agonist-conjugated hepatitis B virus (HBV) proteins (HBV-Ag) to overcome established hepatitis B surface antigen (HBsAg)-specific immune tolerance was explored. Methods: A TLR7/8 agonist, CL097, was conjugated with alum-absorbed HBsAg and hepa...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Ying Wang, Kun Chen, Zhiyuan Wu, Yuetao Liu, Shangmei Liu, Zhongmei Zou, Shu-Hsia Chen, Chunfeng Qu
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2014-12-01
Saila:	International Journal of Infectious Diseases
Gaiak:	Toll-like receptor 7/8 agonists Antigen-specific Th1 responses Immune tolerant state Chronic hepatitis B virus infection
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S1201971214016002
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!